TrialJournal of acquired immune deficiency syndromes (1999)2018

Brief Report: Changes in Plasma RANKL-Osteoprotegerin in a Prospective, Randomized Clinical Trial of Initial Antiviral Therapy: A5260s.

Theodoros Kelesidis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.